Sensitive and Simplified Detection of Antibiotic Influence on the Dynamic and Versatile Changes of Fecal Short-Chain Fatty Acids

PLoS One. 2016 Dec 1;11(12):e0167032. doi: 10.1371/journal.pone.0167032. eCollection 2016.

Abstract

Short-chain fatty acids (SCFAs), produced by anaerobic fermentation of mainly indigestible dietary carbohydrates by gut microbiota, have a profound influence on intestinal function and host energy metabolism. Antibiotics may seriously disturb the balance of fecal SCFAs. To evaluate the impacts of antibiotics on fecal SCFAs produced by gut microbiota, a simple, reproducible and accurate gas chromatography (GC) method, which can simultaneously analyze seven SCFAs in fecal samples, was developed and validated. The ranges of detection and quantitation of the SCFAs reached 0.0868 ~ 0.393 and 0.261 ~ 1.18 μg·mL-1 respectively, in an optimized protocol for SCFAs extraction and analysis that used 10 mL 75% ethanol aqueous solution containing 1% HCl, without ultrasonication. The technique exhibited excellent intra-day (relative standard deviation (RSD) ≤ 2.54%) and inter-day (RSD ≤ 4.33%) precisions for all the SCFAs. Later, we administered broad-spectrum antibiotics, cefdinir or azithromycin to rats and analyzed the alterations in fecal SCFAs. The total amount, types and distribution of nearly all fecal SCFAs were significantly altered during the administration and even after withdrawal of the antibiotics in rats. The effects of cefdinir on the SCFAs were more pronounced than those of azithromycin. Our findings suggest SCFAs may serve as sensitive indicators to monitor the influences of antibiotics on SCFAs originated by intestinal bacteria. Our improved SCFAs analysis method is a potential platform for a standard clinical test of the effects of new antibiotics on SCFAs.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • Azithromycin / pharmacology*
  • Cefdinir
  • Cephalosporins / pharmacology*
  • Chromatography, Gas / methods
  • Chromatography, Gas / standards*
  • Dietary Carbohydrates / administration & dosage
  • Dietary Carbohydrates / metabolism
  • Fatty Acids, Volatile / isolation & purification*
  • Fatty Acids, Volatile / metabolism
  • Feces / chemistry
  • Fermentation / drug effects
  • Gastrointestinal Microbiome / drug effects*
  • Gastrointestinal Microbiome / physiology
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Sensitivity and Specificity

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • Dietary Carbohydrates
  • Fatty Acids, Volatile
  • Azithromycin
  • Cefdinir

Grants and funding

This work was supported by grants from the National Science and Technology Major Projects for "Major New Drugs Innovation and Development" (No. 2015ZX09J15102-004-004 and 2013ZX09201020).